Cargando…

Microglial Activation and Inflammation as a Factor in the Pathogenesis of Progressive Supranuclear Palsy (PSP)

Progressive supranuclear palsy (PSP) is a neurodegenerative disease based on four-repeat tauopathy pathology. Currently, this entity is not fully recognized in the context of pathogenesis or clinical examination. This review evaluates the association between neuroinflammation and microglial activati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alster, Piotr, Madetko, Natalia, Koziorowski, Dariusz, Friedman, Andrzej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492584/ https://www.ncbi.nlm.nih.gov/pubmed/32982676 http://dx.doi.org/10.3389/fnins.2020.00893

Ejemplares similares

Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P)—A Clinical Challenge at the Boundaries of PSP and Parkinson's Disease (PD)
por: Alster, Piotr, et al.
Publicado: (2020)

The Assessment of Subregions in the Frontal Lobe May Be Feasible in the Differential Diagnosis of Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P) and Multiple System Atrophy (MSA)
por: Alster, Piotr, et al.
Publicado: (2022)

Accumulation of Tau Protein, Metabolism and Perfusion—Application and Efficacy of Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) Imaging in the Examination of Progressive Supranuclear Palsy (PSP) and Corticobasal Syndrome (CBS)
por: Alster, Piotr, et al.
Publicado: (2019)

Clinical Phenotypes of Progressive Supranuclear Palsy—The Differences in Interleukin Patterns
por: Madetko-Alster, Natalia, et al.
Publicado: (2023)

Differential Diagnosis of Rare Subtypes of Progressive Supranuclear Palsy and PSP-Like Syndromes—Infrequent Manifestations of the Most Common Form of Atypical Parkinsonism
por: Krzosek, Patrycja, et al.
Publicado: (2022)

The Strengths and Obstacles in the Differential Diagnosis of Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P) and Multiple System Atrophy (MSA) Using Magnetic Resonance Imaging (MRI) and Perfusion Single Photon Emission Computed Tomography (SPECT)
por: Alster, Piotr, et al.
Publicado: (2022)

The Use of Cerebellar Hypoperfusion Assessment in the Differential Diagnosis of Multiple System Atrophy with Parkinsonism and Progressive Supranuclear Palsy-Parkinsonism Predominant
por: Madetko-Alster, Natalia, et al.
Publicado: (2022)

Thalamic and cerebellar hypoperfusion in single photon emission computed tomography may differentiate multiple system atrophy and progressive supranuclear palsy
por: Alster, Piotr, et al.
Publicado: (2019)

Is MRPI 2.0 More Useful than MRPI and M/P Ratio in Differential Diagnosis of PSP-P with Other Atypical Parkinsonisms?
por: Madetko, Natalia, et al.
Publicado: (2022)

The Rate of Decrease in Brain Perfusion in Progressive Supranuclear Palsy and Corticobasal Syndrome May Be Impacted by Glycemic Variability—A Pilot Study
por: Alster, Piotr, et al.
Publicado: (2021)

Effects of robot assisted gait training in progressive supranuclear palsy (PSP): a preliminary report
por: Sale, Patrizio, et al.
Publicado: (2014)

The Role of the Evans Index and the Maximal Width of the Frontal Horns of the Lateral Ventricles in the Diagnostic Imaging of Progressive Supranuclear Palsy and Multiple-System Atrophy
por: Kutyłowski, Michał, et al.
Publicado: (2023)

Inflammation in multiple system atrophy
por: Leńska-Mieciek, Marta, et al.
Publicado: (2023)

The Role of Frontal Assessment Battery and Frontal Lobe Single-Photon Emission Computed Tomography in the Differential Diagnosis of Progressive Supranuclear Palsy Variants and Corticobasal Syndrome—A Pilot Study
por: Alster, Piotr, et al.
Publicado: (2021)

Mechanisms of Neurodegeneration in Various Forms of Parkinsonism—Similarities and Differences
por: Koziorowski, Dariusz, et al.
Publicado: (2021)

Clinical features of progressive supranuclear palsy
por: Wen, Yafei, et al.
Publicado: (2023)

Anti-IgLON5 Disease – The Current State of Knowledge and Further Perspectives
por: Madetko, Natalia, et al.
Publicado: (2022)

DescribePSP and ProPSP: German Multicenter Networks for Standardized Prospective Collection of Clinical Data, Imaging Data, and Biomaterials of Patients With Progressive Supranuclear Palsy
por: Respondek, Gesine, et al.
Publicado: (2021)

MR parkinsonism index predicts vertical supranuclear gaze palsy in patients with PSP–parkinsonism
por: Quattrone, Aldo, et al.
Publicado: (2016)

The Burden of Progressive Supranuclear Palsy on Patients, Caregivers, and Healthcare Systems by PSP Phenotype: A Cross-Sectional Study
por: Pillas, Demetris, et al.
Publicado: (2022)

Waiting impulsivity in progressive supranuclear palsy-Richardson’s syndrome
por: Ahn, Jong Hyeon, et al.
Publicado: (2023)

The Disturbance of Gaze in Progressive Supranuclear Palsy: Implications for Pathogenesis
por: Chen, Athena L., et al.
Publicado: (2010)

Selective frontal neurodegeneration of the inferior fronto-occipital fasciculus in progressive supranuclear palsy (PSP) demonstrated by diffusion tensor tractography
por: Kvickström, Pia, et al.
Publicado: (2011)

Spin-Lattice Distribution MRI Maps Nigral Pathology in Progressive Supranuclear Palsy (PSP) during Life: A Pilot Study
por: Hutchinson, Michael, et al.
Publicado: (2014)

Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care
por: Bluett, Brent, et al.
Publicado: (2021)

Striatal dopaminergic lesions contributed to the disease severity in progressive supranuclear palsy
por: Chen, Ming-Jia, et al.
Publicado: (2022)

Zolpidem in Progressive Supranuclear Palsy
por: Dash, Sandip K.
Publicado: (2013)

Genetics of Progressive Supranuclear Palsy
por: Im, Sun Young, et al.
Publicado: (2015)

Falls in Progressive Supranuclear Palsy
por: Brown, Fraser S., et al.
Publicado: (2019)

Environmental Risk Factors for Progressive Supranuclear Palsy
por: Park, Hee Kyung, et al.
Publicado: (2021)

The evolution of diagnosis from symptom onset to death in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) compared to Parkinson’s disease (PD)
por: Swallow, Diane M. A., et al.
Publicado: (2023)

Predictive Model of Spread of Progressive Supranuclear Palsy Using Directional Network Diffusion
por: Pandya, Sneha, et al.
Publicado: (2017)

Abnormal Resting-State Functional Connectivity in Progressive Supranuclear Palsy and Corticobasal Syndrome
por: Bharti, Komal, et al.
Publicado: (2017)

Midbrain catecholaminergic neurons co-express α-synuclein and tau in progressive supranuclear palsy
por: Erro Aguirre, María Elena, et al.
Publicado: (2015)

Whole-Brain Atrophy Differences between Progressive Supranuclear Palsy and Idiopathic Parkinson’s Disease
por: Guevara, Carlos, et al.
Publicado: (2016)

Reduced phonemic fluency in progressive supranuclear palsy is due to dysfunction of dominant BA6
por: Isella, Valeria, et al.
Publicado: (2022)

Clinical Approach to Supranuclear Brainstem Saccadic Gaze Palsies
por: Lloyd-Smith Sequeira, Alexandra, et al.
Publicado: (2017)

‘Hummingbird’ sign in progressive supranuclear palsy
por: Shukla, Rakesh, et al.
Publicado: (2009)

Clinical Approach to Progressive Supranuclear Palsy
por: Ling, Helen
Publicado: (2016)

Managing cognition in progressive supranuclear palsy
por: Rittman, Timothy, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_h3lddcvuk28ath4h7a9mdut8qg